HEPION PHARMACEUTICALS, INC. Deferred Tax Assets, Operating Loss Carryforwards, Foreign
HEPION PHARMACEUTICALS, INC. (HEPA) had Deferred Tax Assets, Operating Loss Carryforwards, Foreign of $1.98 million as of 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign · last filed 2019-03-14
- 2018-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $1.98M.
- 2017-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $1.14M.
- 2017-06-30: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $560.30K.
- 2016-06-30: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $179.20K.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Foreign |
|---|---|
| 2018-12-31 | $1.98M 10-K · filed 2019-03-14 |
| 2017-12-31 | $1.14M 10-K · filed 2019-03-14 |
| 2017-06-30 | $560.30K 10-KT · filed 2018-03-26 |
| 2016-06-30 | $179.20K 10-KT · filed 2018-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |